Title:
血漿カリクレインの阻害薬
Document Type and Number:
Japanese Patent JP5322935
Kind Code:
B2
Abstract:
The present invention provides compounds that inhibit the activity of plasma kallikrein (PK) and methods of preventing and treating the formation of thrombin during or after a PK dependent disease or condition, for example, after fibrinolysis treatment.
Inventors:
Sinha Skanto
Chilcotte Tammy Joe
Chilcotte Tammy Joe
Application Number:
JP2009522995A
Publication Date:
October 23, 2013
Filing Date:
July 30, 2007
Export Citation:
Assignee:
Activ Site Pharmaceuticals Incorporated
International Classes:
C07D207/34; A61K31/341; A61K31/343; A61K31/381; A61K31/40; A61K31/402; A61K31/404; A61K31/415; A61K31/4192; A61K31/426; A61K31/4436; A61K31/4439; A61K39/395; A61P1/04; A61P3/10; A61P7/02; A61P9/10; A61P19/02; A61P25/04; A61P29/00; A61P31/04; A61P43/00; C07D209/42; C07D231/14; C07D249/04; C07D277/20; C07D277/56; C07D307/68; C07D307/85; C07D333/38; C07D333/68; C07D333/70; C07D401/06; C07D409/04
Domestic Patent References:
| JP2002507968A | ||||
| JP2001527066A |
Foreign References:
| WO2006027135A1 |
Attorney, Agent or Firm:
Hatsushi Shimizu
Toshi Gobe
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Ryuichi Inoue
Masato Ozeki
Toshi Gobe
Koichi Niimi
Tomohiko Kobayashi
Shinichi Watanabe
Ryuichi Inoue
Masato Ozeki